Liraglutide improves depressive and cognitive deficits in a high-fat diet rat model of obesity: the role of hippocampal autophagy and the PI3K/Akt/mTOR pathway
- PMID: 40526304
- DOI: 10.1007/s00213-025-06834-7
Liraglutide improves depressive and cognitive deficits in a high-fat diet rat model of obesity: the role of hippocampal autophagy and the PI3K/Akt/mTOR pathway
Abstract
Rationale: Psychiatric disorders are a largely elusive aspect of obesity, representing a growing public health concern. In this regard, a large body of evidence indicates a pivotal role of disturbed autophagic flux in the pathogenesis of obesity-associated neuropsychiatric deficits.
Objectives: This work was designed to evaluate the effects of the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide, which is increasingly utilized for the management of chronic obesity, on the depressive/cognitive deficits in the high-fat diet (HFD) rat model of obesity with an emphasis on its hippocampal mechanistic backgrounds.
Methods: The effects of chronic liraglutide administration (subcutaneous; 300 µg/kg/day for 28 days) were investigated on depressive-like phenotypes, cognitive deficits, and hippocampal phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mechanistic target of rapamycin (mTOR)-regulated autophagy.
Results: Chronic liraglutide treatment amended the HFD-induced depressive-like phenotype (in the sucrose preference and the forced swimming tests) and cognitive deficits (in the Morris water maze test). Moreover, liraglutide enhanced the hippocampal expression of brain-derived neurotrophic factor (BDNF), PI3K, Akt, p-Akt, and p-mTOR and downregulated the expression of the autophagic markers (Beclin-1, LC3) and the inflammatory markers (TNF-α, IL-6) with amelioration of HFD-induced hippocampal neurodegeneration.
Conclusions: This work highlights the antidepressant and pro-cognitive properties of liraglutide in HFD-exposed rats, which could be mediated through amelioration of the disrupted PI3K/Akt/mTOR signaling activity with a possible impedance of the exaggerated autophagy-mediated neurodegenerative cascades. Indeed, this study highlights that liraglutide is not only effective in weight control, but its effects also extend to managing obesity-related psychiatric disorders.
Keywords: Autophagy; Cognitive dysfunction; Depression; High-fat diet; Hippocampus; Liraglutide.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: The study was conducted in accordance with EU Directive 2010/63/EU for animal experiments and was approved by the Research Ethics Committee of the Faculty of Medicine, Ain Shams University (FMASU-REC). FMASU-REC operates under Federal Wide Assurance. No. FWA 000017585 (approval number: FMASU R231/2022). Consent to participate: Not applicable. Consent to publish: Not applicable. Competing interests: On behalf of all authors, the corresponding author states that there is no conflict of interest. Conflict of interest: All authors declared that there is no conflict of interest.
Similar articles
-
Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats.Mol Med Rep. 2018 Aug;18(2):2449-2457. doi: 10.3892/mmr.2018.9180. Epub 2018 Jun 18. Mol Med Rep. 2018. PMID: 29916537
-
Autophagy dysfunction contributes to NLRP1 inflammasome-linked depressive-like behaviors in mice.J Neuroinflammation. 2024 Jan 4;21(1):6. doi: 10.1186/s12974-023-02995-4. J Neuroinflammation. 2024. PMID: 38178196 Free PMC article.
-
Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats.Mol Neurobiol. 2017 Oct;54(8):5815-5828. doi: 10.1007/s12035-016-0129-3. Epub 2016 Sep 22. Mol Neurobiol. 2017. PMID: 27660271
-
Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes.Neuropharmacology. 2018 Mar 15;131:316-325. doi: 10.1016/j.neuropharm.2018.01.001. Epub 2018 Jan 3. Neuropharmacology. 2018. PMID: 29305122
-
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.Behav Brain Res. 2017 Mar 15;321:157-169. doi: 10.1016/j.bbr.2017.01.004. Epub 2017 Jan 3. Behav Brain Res. 2017. PMID: 28062257
References
-
- Abdullah RK, Issa RA, Abu-Samak M, Mohammad BA, Abbas MA, Awwad SH (2024) Nephroprotective effects of Equisetum ramosissimum L. extract in streptozotocin-induced diabetic rats. Pharmacia 71:1–1. https://doi.org/10.3897/pharmacia.71.e113659 - DOI
-
- Aboul-Fotouh S (2013) Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats. Pharmacol Biochem Behav 104:105–112. https://doi.org/10.1016/j.pbb.2012.12.027 - DOI - PubMed
-
- An JR, Liu JT, Gao XM, Wang QF, Sun GY, Su JN, Zhang C, Yu JX, Yang YF, Shi Y (2023) Effects of liraglutide on astrocyte polarization and neuroinflammation in db/db mice: focus on iron overload and oxidative stress. Front Cell Neurosci 17:1136070. https://doi.org/10.3389/fncel.2023.1136070 - DOI - PubMed - PMC
-
- Bancroft JD, Gamble M (2008) Theory and practice of histological techniques, 6th edn. Churchill Livingstone, Elsevier, Philadelphia
-
- Behrooz AB, Cordani M, Fiore A, Donadelli M, Gordon JW, Klionsky DJ, Ghavami S (2024) The obesity-autophagy-cancer axis: mechanistic insights and therapeutic perspectives. Semin Cancer Biol 99:24–44. https://doi.org/10.1016/j.semcancer.2024.01.003 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous